Teitelbaum Isaac, Finkelstein Frederic O
Division of Kidney Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA.
Kidney Int Rep. 2023 Jul 25;8(10):1917-1923. doi: 10.1016/j.ekir.2023.07.012. eCollection 2023 Oct.
Peritoneal dialysis (PD) offers lifestyle advantages over in-center hemodialysis (HD) and is less costly. However, in the United States, less than 12% of end-stage kidney disease (ESKD) patients are maintained on this modality. In this brief review, we discuss some of the factors underlying the low prevalence of PD. These include inadequate patient education, a shortage of sufficiently well-trained medical and nursing personnel, absence of infrastructure to support urgent start PD, and lack of support for assisted PD, among other factors. Understanding and addressing these various issues may help increase the prevalence of PD in the United States and globally.
腹膜透析（PD）相较于中心血液透析（HD）具有生活方式上的优势，且成本更低。然而，在美国，终末期肾病（ESKD）患者中接受这种透析方式的不到12%。在这篇简短的综述中，我们讨论了导致PD低普及率的一些因素。这些因素包括患者教育不足、缺乏训练有素的医护人员、缺乏支持紧急开始PD的基础设施以及对辅助PD缺乏支持等。了解并解决这些各种问题可能有助于提高PD在美国乃至全球的普及率。
